Soon Khai Low

Soon Khai Low

Auto-generated profile, based on publicly available information

Soon Khai Low

Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Parasitology International
Verified
Journal Article
Closed access
PMPeterson Gitonga Mathenge
Peterson Gitonga Mathenge
SLSoon Khai Low
Soon Khai Low
NVNguyen Lam Vuong
Nguyen Lam Vuong
MMMuawia Yousif Fadlelmola Mohamed
Muawia Yousif Fadlelmola Mohamed
HFHazem Abdelkarem Faraj
Hazem Abdelkarem Faraj
KHKenji Hirayama
Kenji Hirayama

23 March 2019 in Head & Neck
Verified
Journal Article
Closed access
PDF file
KEKhaled Mosaad Elhusseiny
Khaled Mosaad Elhusseiny
FAFatma Abd‐Elshahed Abd‐Elhay
Fatma Abd‐Elshahed Abd‐Elhay
MKMohamed Gomaa Kamel
Mohamed Gomaa Kamel
HHHeba Hassan Abd El Hamid Hassan
Heba Hassan Abd El Hamid Hassan
HTHeba Hussien Muhammad El Tanany
Heba Hussien Muhammad El Tanany
Nguyen Tien HuyNguyen Tien Huy
Nguyen Tien Huy

19 July 2019 in Leukemia & Lymphoma
Verified
Journal Article
Closed access
SLSoon Khai Low
Soon Khai Low
AZAhmad Zayan
Ahmad Zayan
OIObaida Istanbuly
Obaida Istanbuly
MTMinh Duc Nguyen Tran
Minh Duc Nguyen Tran
AEAmr Ebied
Amr Ebied
Nguyen Tien HuyNguyen Tien Huy
Nguyen Tien Huy
Primary pulmonary lymphomas (PPLs) are rare lymphoproliferative malignancies arising from the lungs. The prognostic factors and optimal management of PPL have not been clearly defined due to its rarity. This study sought to characterize the significant prognostic factors and develop a validated nomogram for individualized prediction of survival outcomes in patients with PPL. A total of 2325 patients diagnosed with PPL between 1983 and 2010 were identified using the Surveillance, Epidemiology, and End Results (SEER) database. Older age at diagnosis, males, Hispanic race, non-marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue histology, Ann Arbor stage IV were significantly associated with worse OS on multivariable analysis. All treatment modalities, including chemotherapy, surgery, and radiotherapy were independent predictors of survival on univariable analysis. The nomogram built demonstrated good discriminative ability and calibration, with the C-index of 0.690 and 0.730 in the training and validation cohorts, respectively.

1 December 2018 in Clinical Breast Cancer
Verified
Journal Article
Closed access
FAFatma Abd-Elshahed Abd-Elhay
Fatma Abd-Elshahed Abd-Elhay
KEKhaled Mosaad Elhusseiny
Khaled Mosaad Elhusseiny
MKMohamed Gomaa Kamel
Mohamed Gomaa Kamel
SLSoon Khai Low
Soon Khai Low
TSTo Kim Sang
To Kim Sang
Nguyen Tien HuyNguyen Tien Huy
Nguyen Tien Huy
1

22 June 2022 in Leukemia Research Reports
Verified
Journal Article
Open access
SLSoon Khai Low
Soon Khai Low
SNSuparna Nanua
Suparna Nanua
MPMehul Patel
Mehul Patel
ARAnne S Renteria
Anne S Renteria
A patient with history of myelodysplastic syndrome (MDS) presented with multifocal pneumonia and was found to have Philadelphia chromosomepositive (Ph+) acute myeloid leukemia (AML). A tyrosine kinase inhibitor (TKI) was added to decitabine and venetoclax combination, providing a molecular and cytogenetic complete response despite additional cytogenetic and molecular abnormalities. She remains in remission after eleven cycles of treatment. Our report describes the tolerability and success of a triplet regimen that incorporates a TKI to a backbone of decitabine and venetoclax in a patient with high-risk disease and with significant comorbidities.

11 November 2023 in American Journal of Hematology
Verified
Journal Article
Closed access
NNNiraj Neupane
Niraj Neupane
SLSoon K. Low
Soon K. Low
HKHimal Kharel
Himal Kharel
SBSanket Bhattarai
Sanket Bhattarai
STSangharsha Thapa
Sangharsha Thapa
PKPeter Kouides
Peter Kouides